| An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival LD Miller, J Smeds, J George, VB Vega, L Vergara, A Ploner, Y Pawitan, ... Proceedings of the National Academy of Sciences 102 (38), 13550-13555, 2005 | 1486 | 2005 |
| A global map of p53 transcription-factor binding sites in the human genome CL Wei, Q Wu, VB Vega, KP Chiu, P Ng, T Zhang, A Shahab, HC Yong, ... Cell 124 (1), 207-219, 2006 | 1468 | 2006 |
| Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts Y Pawitan, J Bjöhle, L Amler, AL Borg, S Egyhazi, P Hall, X Han, ... Breast cancer research 7, 1-12, 2005 | 933 | 2005 |
| High-fidelity mRNA amplification for gene profiling E Wang, LD Miller, GA Ohnmacht, ET Liu, FM Marincola Nature biotechnology 18 (4), 457-459, 2000 | 870 | 2000 |
| Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer AV Ivshina, J George, O Senko, B Mow, TC Putti, J Smeds, T Lindahl, ... Cancer research 66 (21), 10292-10301, 2006 | 840 | 2006 |
| Ferroportin and iron regulation in breast cancer progression and prognosis ZK Pinnix, LD Miller, W Wang, R D’Agostino Jr, T Kute, MC Willingham, ... Science translational medicine 2 (43), 43ra56-43ra56, 2010 | 548 | 2010 |
| Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-κB-responsive genes in cervical keratinocytes M Nees, JM Geoghegan, T Hyman, S Frank, L Miller, CD Woodworth Journal of virology 75 (9), 4283-4296, 2001 | 518 | 2001 |
| Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer CN Landen Jr, B Goodman, AA Katre, AD Steg, AM Nick, RL Stone, ... Molecular cancer therapeutics 9 (12), 3186-3199, 2010 | 474 | 2010 |
| Iron addiction: a novel therapeutic target in ovarian cancer D Basuli, L Tesfay, Z Deng, B Paul, Y Yamamoto, G Ning, W Xian, ... Oncogene 36 (29), 4089-4099, 2017 | 424 | 2017 |
| Transcriptome analysis of zebrafish embryogenesis using microarrays S Mathavan, SGP Lee, A Mak, LD Miller, KRK Murthy, KR Govindarajan, ... PLoS genetics 1 (2), e29, 2005 | 394 | 2005 |
| Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients S Calza, P Hall, G Auer, J Bjöhle, S Klaar, U Kronenwett, ET Liu, L Miller, ... Breast Cancer Research 8, 1-9, 2006 | 380 | 2006 |
| Discovery of estrogen receptor α target genes and response elements in breast tumor cells CY Lin, A Ström, VB Vega, S Li Kong, A Li Yeo, JS Thomsen, WC Chan, ... Genome biology 5, 1-18, 2004 | 371 | 2004 |
| Metabolic changes in blood and liver during development and early treatment of experimental fatty liver and ketosis in cows JJ Veenhuizen, JK Drackley, MJ Richard, TP Sanderson, LD Miller, ... Journal of dairy science 74 (12), 4238-4253, 1991 | 366 | 1991 |
| Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression SH Lam, YL Wu, VB Vega, LD Miller, J Spitsbergen, Y Tong, H Zhan, ... Nature biotechnology 24 (1), 73-75, 2006 | 354 | 2006 |
| Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness E Wang, LD Miller, GA Ohnmacht, S Mocellin, A Perez-Diez, D Petersen, ... Cancer research 62 (13), 3581-3586, 2002 | 320 | 2002 |
| Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy S Gnjatic, V Bronte, LR Brunet, MO Butler, ML Disis, J Galon, ... Journal for immunotherapy of cancer 5, 1-18, 2017 | 248 | 2017 |
| Sal‐like protein 4 (SALL4), a stem cell biomarker in liver cancers T Oikawa, A Kamiya, M Zeniya, H Chikada, AD Hyuck, Y Yamazaki, ... Hepatology 57 (4), 1469-1483, 2013 | 234 | 2013 |
| An iron regulatory gene signature predicts outcome in breast cancer LD Miller, LG Coffman, JW Chou, MA Black, J Bergh, R D'Agostino Jr, ... Cancer research 71 (21), 6728-6737, 2011 | 234 | 2011 |
| Identification of cell cycle-regulated genes in fission yeast X Peng, RKM Karuturi, LD Miller, K Lin, Y Jia, P Kondu, L Wang, LS Wong, ... Molecular biology of the cell 16 (3), 1026-1042, 2005 | 223 | 2005 |
| Tumor mutational burden is a determinant of immune-mediated survival in breast cancer A Thomas, ED Routh, A Pullikuth, G Jin, J Su, JW Chou, KA Hoadley, ... Oncoimmunology 7 (10), e1490854, 2018 | 221 | 2018 |
